Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay.

Autor: D Mouttet, M Laé, M Caly, D Gentien, S Carpentier, H Peyro-Saint-Paul, A Vincent-Salomon, R Rouzier, B Sigal-Zafrani, X Sastre-Garau, F Reyal

Publikováno v: PLoS ONE, Vol 11, Iss 2, p e0146474 (2016)

BACKGROUND:Hormone receptor status and HER2 status are of critical interest in determining the prognosis of breast cancer patients. Their status is routinely assessed by immunohistochemistry (IHC). However, it is subject to intra-laboratory and inter

Externí odkaz: https://doaj.org/article/cc538448f6b842be9acb14d71935b862

VP17.02: Description and clinical validation of a real‐time AI diagnostic companion for fetal ultrasound examination

Autor: F. Loge, H. Peyro-Saint-Paul, Yves Ville, E. Le Pennec, Stéphanie Allassonnière, Emmanuel Spaggiari, S. Rojo, Julien Stirnemann, Rémi Besson, N. Bourgon

Publikováno v: Ultrasound in Obstetrics & Gynecology. 58:169-170

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::86a4788cdcb13633adc5360b962a6396
https://doi.org/10.1002/uog.24291

PATHOLOGY

Autor: J.-i. Adachi, K. Totake, M. Shirahata, K. Mishima, T. Suzuki, T. Yanagisawa, K. Fukuoka, R. Nishikawa, A. Arimappamagan, N. Manoj, A. Mahadevan, D. Bhat, H. Arvinda, B. Indiradevi, S. Somanna, B. Chandramouli, S. A. Petterson, S. K. Hermansen, R. H. Dahlrot, S. Hansen, B. W. Kristensen, F. Carvalho, S. Jalali, S. Singh, S. Croul, K. Aldape, G. Zadeh, J. Choi, S.-H. Park, S. K. Khang, Y.-L. Suh, S. P. Kim, Y. S. Lee, S. H. Kim, S. Coberly, K. Samayoa, Y. Liu, P. Kiaei, J. Hill, S. Patterson, M. Damore, S. Dahiya, R. Emnett, J. Phillips, D. Haydon, J. Leonard, A. Perry, D. Gutmann, S. Epari, S. Ahmed, M. Gurav, S. Raikar, A. Moiyadi, P. Shetty, T. Gupta, R. Jalali, J. Georges, A. Zehri, E. Carlson, N. Martirosyan, A. Elhadi, J. Nichols, L. Ighaffari, J. Eschbacher, B. Feuerstein, T. Anderson, M. Preul, K. Jensen, P. Nakaji, H. Girardi, F. Monville, S. Carpentier, M. Giry, J. Voss, R. Jenkins, B. Boisselier, V. Frayssinet, C. Poggionovo, A. Catteau, K. Mokhtari, M. Sanson, H. Peyro-Saint-Paul, C. Giannini, T. Hide, H. Nakamura, K. Makino, S. Yano, S. Anai, N. Shinojima, J.-i. Kuroda, T. Takezaki, J.-i. Kuratsu, F. Higuchi, H. Matsuda, K. Iwata, K. Ueki, P. Kim, J. Kong, L. Cooper, F. Wang, J. Gao, G. Teodoro, L. Scarpace, T. Mikkelsen, M. Schniederjan, C. Moreno, J. Saltz, D. Brat, U. Cho, Y.-K. Hong, R. Lober, L. Lu, M. H. Gephart, P. Fisher, M. Miyazaki, H. Nishihara, T. Itoh, M. Kato, S. Fujimoto, T. Kimura, M. Tanino, S. Tanaka, N. Nguyen, G. Moes, J. L. Villano, H. Kanno, Y. Kato, T. Ohnishi, H. Harada, S. Ohue, S. Kouno, A. Inoue, D. Yamashita, S. Okamoto, M. Nitta, Y. Muragaki, T. Maruyama, T. Sawada, T. Komori, T. Saito, Y. Okada, S. B. Omay, J. M. Gunel, V. E. Clark, J. Li, E. Z. E. Omay, A. Serin, L. E. Kolb, R. M. Hebert, K. Bilguvar, K. Ozduman, M. N. Pamir, T. Kilic, J. Baehring, J. M. Piepmeier, C. W. Brennan, J. Huse, P. H. Gutin, K. Yasuno, A. Vortmeyer, M. Gunel, S. Pugh, C. L. Rogers, D. Brachman, W. McMillan, J. Jenrette, I. Barani, D. Shrieve, A. Sloan, M. Mehta, A. Prabowo, A. Iyer, T. Veersema, J. Anink, A. S.-v. Meeteren, W. Spliet, P. van Rijen, T. Ferrier, D. Capper, M. Thom, E. Aronica, T. Chharchhodawala, M. Sable, M. C. Sharma, C. Sarkar, V. Suri, M. Singh, V. Santosh, B. Thota, M. Srividya, K. Sravani, S. Shwetha, A. Arivazhagan, K. Thennarasu, A. Hegde, P. Kondaiah, K. Somasundaram, M. Rao, V. P. Kumar, A. Shastry, R. Narayan, S. Naz, S. Venneti, M. Garimella, L. Sullivan, D. Martinez, A. Heguy, M. Santi, C. Thompson, A. Judkins, Z. Voronovich, L. Chen, K. Clark, M. Walsh, J. Mannas, C. Horbinski, B. Wiestler, T. Holland-Letz, A. Korshunov, A. von Deimling, S. M. Pfister, M. Platten, M. Weller, W. Wick, G. Zieman, C. Dardis, L. Ashby

Publikováno v: Neuro-Oncology. 15:iii156-iii164

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8962aafe4ce5d700f192fc9193a4e7b3
https://doi.org/10.1093/neuonc/not184

A personalized adjuvant treatment for women over 70 presenting with a luminal breast cancer? ASTER 70s or an ongoing phase III trial with parallel cohort by the UNICANCER GERICO and UCBG groups for an ongoing question…

Autor: Aurélien Latouche, M. Lacroix-Triki, Sandrine Baffert, Veronique Girre, O. Rigal, Christine Orsini, Paul-Henri Cottu, Franck Bonnetain, H. Peyro Saint-Paul, Etienne Brain, Emmanuelle Bourbouloux, Florence Rollot, Hervé Curé, Gilles Romieu, V. Servent, J.-M. Ferrero, Hervé Bonnefoi, C. Léger-Falandry

Publikováno v: Journal of Geriatric Oncology. 3:S34-S35

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5138a283dd48d6a0e13d7b14b0fd43d3
https://doi.org/10.1016/j.jgo.2012.10.005

ASTER 70s UNICANCER phase III Trial: Can a genomic prognosticator help tailoring adjuvant systemic treatment for luminal breast carcinoma in elderly women?

Autor: Nicole Tubiana-Mathieu, Sylvie Kirscher, H. Peyro-saint-paul, Gilles Romieu, Olivier Mir, Etienne Brain, Olivier Rigal, M. Lacroix-Triki, Emmanuel Blot, D. Allouache, Emmanuelle Bourbouloux, Coraline Dubot, Florence Rollot, Hervé Curé, Paul-Henri Cottu, J.-M. Ferrero, Franck Bonnetain, C. Lefeuvre, E. Malaurie, Christine Orsini

Publikováno v: Journal of Geriatric Oncology. 5:S28

adjuvant chemotherapy (aCT) and adjuvant hormonal therapy (aHT) of newly-diagnosed patients with early-stage breast cancer. Methods: Participants included patients diagnosed with stages I–II disease, aged 40 years or older at diagnosis. Patients we

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2bd1804f582bdd10d925edb888d85ee4
https://doi.org/10.1016/j.jgo.2014.09.039